Moderna, Inc. reports $145 million revenue for quarter ended June 30, 2026, up 2.1%
Moderna, Inc. reported revenue of $145 million for the quarter ended June 30, 2026, an increase of 2.1% from the same quarter a year earlier ($142 million).
For the same period it posted a net loss of $782 million, or $-1.97 per diluted share (-2.13 a year earlier).
That is a net margin of -539.3%.
On Sanad's AAOIFI Standard 21 screen, Moderna, Inc. is currently not compliant: interest-bearing debt is 0.7% of market capitalisation (limit 30%), and impure income is 16.2% of revenue (limit 5%).
Is Moderna, Inc. halal?
See the full AAOIFI screening of Moderna, Inc.
See the full AAOIFI screening of Moderna, Inc.
Source: 10-Q filed with the U.S. Securities and Exchange Commission on July 31, 2026. View the filing. Figures are as reported in the filing. This is information, not investment advice.